SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-060352
Filing Date
2015-08-17
Accepted
2015-08-17 16:16:10
Documents
5
Period of Report
2015-08-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-17784_18k.htm 8-K 67010
2 EX-4.1 a15-17784_1ex4d1.htm EX-4.1 1157651
3 EX-10.1 a15-17784_1ex10d1.htm EX-10.1 2834815
4 EX-99.1 a15-17784_1ex99d1.htm EX-99.1 48236
5 GRAPHIC g177841mmi001.gif GRAPHIC 3799
  Complete submission text file 0001104659-15-060352.txt   4114585
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10865 | Film No.: 151059130
SIC: 2834 Pharmaceutical Preparations